CIK 0001953926 · <br>Emerging growth company
Zenas BioPharma, Inc.
Sign in to watch- Ticker
- ZBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-271-2954
- Business address
- 852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
- Former names
- Zenas BioPharma (Cayman) Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | Allen Patricia L Director | Purchase | +5,000 | $23.77 | $119K | 5,000 |
| 2026-02-12 | Allen Patricia L Director | Purchase | +5,700 | $24.34 | $139K | 10,700 |
| 2026-02-12 | Allen Patricia L Director | Purchase | +5,000 | $26.50 | $133K | 15,700 |
| 2026-02-11 | Lu Hongbo Director | Purchase | +25,985 | $22.50 | $585K | 347,968 |
| 2026-02-05 | Farmer Joseph L See Remarks | Grant or award | +974 | $13.35 | $13K | 974 |
| 2026-02-05 | Fox Jennifer A. See Remarks | Grant or award | +1,592 | $13.35 | $21K | 1,592 |
| 2026-02-02 | MOULDER LEON O JR Chief Executive Officer | Purchase | +57,000 | $17.96 | $1.0M | 423,155 |
| 2026-01-09 | MOULDER LEON O JR Chief Executive Officer | Purchase | +20,000 | $16.55 | $331K | 366,155 |
| 2026-01-08 | MOULDER LEON O JR Chief Executive Officer | Purchase | +30,000 | $16.30 | $489K | 346,155 |
| 2026-01-07 | MOULDER LEON O JR Chief Executive Officer | Purchase | +50,000 | $16.38 | $819K | 316,155 |
| 2025-10-09 | Nunn Jason Raleigh Director | Purchase | +63,158 | $19.00 | $1.2M | 1,173,395 |
| 2025-10-09 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +63,158 | $19.00 | $1.2M | 1,173,395 |
| 2025-10-09 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +63,157 | $19.00 | $1.2M | 1,917,895 |
| 2025-10-09 | ENRIGHT PATRICK G Director | Purchase | +105,265 | $19.00 | $2.0M | 1,832,669 |
| 2025-10-09 | ENRIGHT PATRICK G Director | Purchase | +11,990 | $20.85 | $250K | 11,990 |
| 2025-10-07 | MOULDER LEON O JR See Remarks | Purchase | +36,928 | $20.85 | $770K | 36,928 |
| 2025-10-07 | Fairmount Funds Management LLC Director | Purchase | +316,219 | $19.00 | $6.0M | 2,209,025 |
| 2025-10-07 | Lu Hongbo Director | Purchase | +263,160 | $19.00 | $5.0M | 321,983 |
| 2025-06-10 | Fox Jennifer A. See Remarks | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-06-10 | Oliveira Orlando See Remarks | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 2 of 8 · 145 trades